180 related articles for article (PubMed ID: 27557389)
1. Advances in the diagnosis and control of lymphomas.
Candelaria M
Salud Publica Mex; 2016 Apr; 58(2):296-301. PubMed ID: 27557389
[TBL] [Abstract][Full Text] [Related]
2. [Lymphomas: A therapeutic update].
Wolfromm A; Delarue R
Rev Med Interne; 2017 Oct; 38(10):685-690. PubMed ID: 28958786
[TBL] [Abstract][Full Text] [Related]
3. [New treatments of malignant lymphoma--a review].
Mark M; Cerny T
Ther Umsch; 2010 Oct; 67(10):537-43. PubMed ID: 20886460
[TBL] [Abstract][Full Text] [Related]
4. [Practical approach of lymphomas: major role of general practitioner who has to face all these emerging drugs].
Bron D; Dewind R; Cantinieaux B; Woff E; Roelandts M; Moerman C; Lemort M; Heimann P; De Wilde V; Meuleman N; Maerevoet M
Rev Med Brux; 2015 Sep; 36(4):237-47. PubMed ID: 26591307
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).
Lefebvre C; Callet-Bauchu E; Chapiro E; Nadal N; Penther D; Poirel HA
Ann Biol Clin (Paris); 2016 Oct; 74(5):568-587. PubMed ID: 27707672
[TBL] [Abstract][Full Text] [Related]
6. [Histological transformation of low malignancy lymphoproliferative syndromes. Clinical and developmental study of 32 cases].
Coiffier B; Sebban C; Berger F; Bryon PA; Magaud JP; Ffrench M; Gentilhomme O; Fière D; Viala JJ
Presse Med; 1985 Jun; 14(22):1229-30, 1235-6. PubMed ID: 3160019
[TBL] [Abstract][Full Text] [Related]
7. [Colorectal cancer: ten years of illusion of progress but advances are on the horizon].
Shaza L; Charette N; Hendlisz A
Rev Med Brux; 2015 Sep; 36(4):263-6. PubMed ID: 26591311
[TBL] [Abstract][Full Text] [Related]
8. Lymphoproliferative Disease of the Orbit.
Li EY; Yuen HK; Cheuk W
Asia Pac J Ophthalmol (Phila); 2015; 4(2):106-11. PubMed ID: 26065355
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lymphomas.
Seçkin D; Hofbauer GF
Cancer Treat Res; 2009; 146():343-51. PubMed ID: 19415215
[No Abstract] [Full Text] [Related]
10. A decade of progress in lymphoma: advances and continuing challenges.
Flowers CR; Armitage JO
Clin Lymphoma Myeloma Leuk; 2010 Dec; 10(6):414-23. PubMed ID: 21156459
[TBL] [Abstract][Full Text] [Related]
11. [New therapeutic strategies in oncology].
Bohuon C
Ann Pharm Fr; 2010 Jul; 68(4):203-4. PubMed ID: 20637352
[No Abstract] [Full Text] [Related]
12. An Update on the Use of Immunotherapy in the Treatment of Lymphoma.
Marron TU; Kalac M; Brody J
Curr Hematol Malig Rep; 2017 Aug; 12(4):282-289. PubMed ID: 28735365
[TBL] [Abstract][Full Text] [Related]
13. Identifying professional education gaps and barriers in multiple myeloma patient care: findings of the Managing Myeloma Continuing Educational Initiative Advisory Committee.
Raje N; Faiman B; Harvey RD; Kurtin SE; Lonial S; Kumar SK; Cohen AD; Conde MA; Giralt SA; Recine MS; Tombler ER; Stadtmauer E; Jagannath S; Anderson KC;
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):356-69. PubMed ID: 25066040
[TBL] [Abstract][Full Text] [Related]
14. [Research evolutions in immuno-oncology and their impact on the management of patients treated with immunotherapy].
Caux C
Bull Cancer; 2020 Jan; 107(1):6-9. PubMed ID: 31954504
[TBL] [Abstract][Full Text] [Related]
15. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
[TBL] [Abstract][Full Text] [Related]
16. Lymphoma in Adolescents and Young Adults: Current Perspectives.
Hochberg J; Cairo MS
Cancer J; 2018; 24(6):285-300. PubMed ID: 30480573
[TBL] [Abstract][Full Text] [Related]
17. Making the investigational oncology pipeline more efficient and effective: are we headed in the right direction?
LoRusso PM; Anderson AB; Boerner SA; Averbuch SD
Clin Cancer Res; 2010 Dec; 16(24):5956-62. PubMed ID: 21169248
[TBL] [Abstract][Full Text] [Related]
18. Clinical development of combination strategies in immunotherapy: are we ready for more than one investigational product in an early clinical trial?
Perez-Gracia JL; Berraondo P; Martinez-Forero I; Alfaro C; Suarez N; Gurpide A; Sangro B; Hervas-Stubbs S; Ochoa C; Melero JA; Melero I
Immunotherapy; 2009 Sep; 1(5):845-53. PubMed ID: 20636027
[TBL] [Abstract][Full Text] [Related]
19. Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?
Epperla N; Fenske TS; Lazarus HM; Hamadani M
Bone Marrow Transplant; 2015 Nov; 50(11):1393-404. PubMed ID: 26281033
[TBL] [Abstract][Full Text] [Related]
20. Investigational histone deacetylase inhibitors for non-Hodgkin lymphomas.
Watanabe T
Expert Opin Investig Drugs; 2010 Sep; 19(9):1113-27. PubMed ID: 20649502
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
